Literature DB >> 15963945

Suppression of hLRH-1 mediated by a DNA vector-based RNA interference results in cell cycle arrest and induction of apoptosis in hepatocellular carcinoma cell BEL-7402.

Shuiliang Wang1, Fenghua Lan, Lianghu Huang, Lihong Dong, Zhongyong Zhu, Zonghai Li, Youhua Xie, Jiliang Fu.   

Abstract

RNA interference (RNAi) is the process by which double-stranded RNA directs sequence-specific degradation of mRNA. A DNA vector-based approach has been shown to be able to trigger RNA interference in mammalian cells successfully. LRH-1 is an orphan nuclear receptor predominantly expressed in tissues of endodermal origin, where it controls development and cholesterol homeostasis. In the present study, we demonstrated that the expression of hLRH-1 and cyclin E1 in BEL-7402 cells could be suppressed by up to approximately 80% via DNA vector-based RNA interference. The suppression of hLRH-1 resulted in cell cycle arrest mediated by the down-regulation of cyclin E1. Induction of apoptosis and down-regulation of Gadd45beta were also shown in hLRH-1 knock down BEL-7402 cells. These results, together with the findings that Gadd45beta remained unchanged in cyclin E1 RNAi cells, suggested that the induction of apoptosis by knock down of hLRH-1 was closely related to the down-regulation of Gadd45beta.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963945     DOI: 10.1016/j.bbrc.2005.05.186

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.

Authors:  Frank Batista; Daniel Vaiman; Jean Dausset; Marc Fellous; Reiner A Veitia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

Review 2.  MiR-139-5p: promising biomarker for cancer.

Authors:  He-da Zhang; Lin-hong Jiang; Da-wei Sun; Jian Li; Jin-hai Tang
Journal:  Tumour Biol       Date:  2015-02-19

3.  Silencing LRH-1 in colon cancer cell lines impairs proliferation and alters gene expression programs.

Authors:  James R Bayrer; Sridevi Mukkamala; Elena P Sablin; Paul Webb; Robert J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

4.  POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells.

Authors:  Monica Malheiros França; Bruno Ferraz-de-Souza; Antonio Marcondes Lerario; Maria Candida Barisson Villares Fragoso; Claudimara Ferini Pacicco Lotfi
Journal:  Biomed Res Int       Date:  2015-09-02       Impact factor: 3.411

5.  Tumor-suppressive function of miR-139-5p in esophageal squamous cell carcinoma.

Authors:  Ran Liu; Miao Yang; Yanli Meng; Juan Liao; Jingyi Sheng; Yuepu Pu; Lihong Yin; Sun Jung Kim
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

6.  Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy.

Authors:  Ling-Li Huang; Ling-Wei Huang; Lei Wang; Ben-Ding Tong; Qing Wei; Xuan-Sheng Ding
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

7.  LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21.

Authors:  Lijia Xiao; Yuliang Wang; Weicheng Liang; Liping Liu; Nannan Pan; Huimin Deng; Luqian Li; Chang Zou; Franky Leung Chan; Yiwen Zhou
Journal:  Cancer Manag Res       Date:  2018-08-01       Impact factor: 3.989

8.  Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog.

Authors:  Ting Ye; Jingyuan Li; Zhiwei Sun; Yongli Liu; Liangsheng Kong; Shixia Zhou; Junlin Tang; Jianyu Wang; H Rosie Xing
Journal:  Cancer Med       Date:  2019-02-10       Impact factor: 4.452

Review 9.  MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potential.

Authors:  Huanhuan Sha; Yujie Gan; Feng Xu; Yue Zhu; Renrui Zou; Weiwei Peng; Zhiya Wu; Rong Ma; Jianzhong Wu; Jifeng Feng
Journal:  J Cell Mol Med       Date:  2022-01-11       Impact factor: 5.310

10.  LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.

Authors:  Yuechao Liu; Ying Xing; Hongmei Wang; Shi Yan; Xinzhu Wang; Li Cai
Journal:  Thorac Cancer       Date:  2018-10-01       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.